Evidence map›Paper›PMID 26464217›Full record

ArticleEuropean journal of immunology2016

Depletion of CD11c⁺ cells in the CD11c.DTR model drives expansion of unique CD64⁺ Ly6C⁺ monocytes that are poised to release TNF-α.

Shivajanani Sivakumaran, Stephen Henderson, Sophie Ward, Pedro Santos E Sousa, Teresa Manzo, Lei Zhang, Thomas Conlan, Terry K Means, Maud D'Aveni, Olivier Hermine and 3 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Selective depletion of a CD64-expressing phagocyte subset mediates protection against toxic kidney injury and failure.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  5. Is Cd11c and Fmc7 Negativity in Chronic Lymphocytic Leukemia Poor Prognostic?Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2020
    Article
  6. Article
  7. Tumor-Resident Dendritic Cells and Macrophages Modulate the Accumulation of TCR-Engineered T Cells in Melanoma.Molecular therapy : the journal of the American Society of Gene Therapy · 2018
    Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Shivajanani SivakumaranInstitute for Immunity and Transplantation, University College London, London, UK.
Stephen HendersonCancer Institute, University College London, London, UK.
Sophie WardInstitute for Immunity and Transplantation, University College London, London, UK.
Pedro Santos E SousaInstitute for Immunity and Transplantation, University College London, London, UK.
Teresa ManzoInstitute for Immunity and Transplantation, University College London, London, UK.
Lei ZhangInstitute for Immunity and Transplantation, University College London, London, UK.
Thomas ConlanInstitute for Immunity and Transplantation, University College London, London, UK.
Terry K MeansMGH Center for Immunology and Inflammatory Diseases, Harvard Medical School, Boston, MA, USA.
Maud D'AveniCNRS UMR 8147, Université Paris Descartes, Faculté de Médecine, Hôpital Necker, Paris, France.
Olivier HermineCNRS UMR 8147, Université Paris Descartes, Faculté de Médecine, Hôpital Necker, Paris, France.
Marie-Thérèse RubioCNRS UMR 8147, Université Paris Descartes, Faculté de Médecine, Hôpital Necker, Paris, France.
Ronjon ChakravertyInstitute for Immunity and Transplantation, University College London, London, UK.
Clare L BennettInstitute for Immunity and Transplantation, University College London, London, UK.
CRUK Lung Cancer Centre of Excellence · GBLondon Cancer · GBUniversity College London · GBHôpital Necker-Enfants Malades · FRCentre National de la Recherche Scientifique · FRHarvard University · US

Funding

Cancer Research UK 20265
6 · The paper itself

Abstract

Dendritic cells (DCs) play a vital role in innate and adaptive immunities. Inducible depletion of CD11c(+) DCs engineered to express a high-affinity diphtheria toxin receptor has been a powerful tool to dissect DC function in vivo. However, despite reports showing that loss of DCs induces transient monocytosis, the monocyte population that emerges and the potential impact of monocytes on studies of DC function have not been investigated. We found that depletion of CD11c(+) cells from CD11c.DTR mice induced the expansion of a variant CD64(+) Ly6C(+) monocyte population in the spleen and blood that was distinct from conventional monocytes. Expansion of CD64(+) Ly6C(+) monocytes was independent of mobilization from the BM via CCR2 but required the cytokine, G-CSF. Indeed, this population was also expanded upon exposure to exogenous G-CSF in the absence of DC depletion. CD64(+) Ly6C(+) monocytes were characterized by upregulation of innate signaling apparatus despite the absence of inflammation, and an increased capacity to produce TNF-α following LPS stimulation. Thus, depletion of CD11c(+) cells induces expansion of a unique CD64(+) Ly6C(+) monocyte population poised to synthesize TNF-α. This finding will require consideration in experiments using depletion strategies to test the role of CD11c(+) DCs in immunity.

Indexed as

AnimalsAntigens, LyCD11c AntigenDendritic CellsFlow CytometryMiceMice, KnockoutMice, TransgenicMonocytesOligonucleotide Array Sequence AnalysisReceptors, IgGTumor Necrosis Factor-alphaAntigens, LyCD11c AntigenLy-6C antigen, mouseReceptors, IgGTumor Necrosis Factor-alphaCD11c.DTRDendritic cellsDepletionDiphtheria toxin receptor (DTR)MonocytesMonocytosis

Identifiers

PMID26464217
PMCPMC4722854
OpenAlexW1892455321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.